EMA to complete rosiglitazone review by September

Thursday 22 July 2010

The European Medicines Agency said it expects to complete its review of the safety of rosiglitazone-containing medicines, including Avandia, by September 2010. The review is looking at the risk of cardiovascular problems with the drugs.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom